chapter 2 review of literature -...
TRANSCRIPT
CHAPTER 2
Review of Literature
This chapter reviews the available Ayurvedic literature on APD concept and the two pairs
of APDs selected for scientific studies. A brief introduction to trans-disciplinary research is
also provided alongside relevant research work to identify substitutes for endangered
medicinal plant species
Review of Literature
15
2.1 Introduction
This chapter presents a systematic review of published literature on the Ayurvedic
concept of APD. Efforts made to establish substitutes for some of the popular, but
endangered herbal drugs in international levels are also presented. It reviews the
botanical candidates of 2 sets of APDs shortlisted for scientific studies, i.e., Ativiṣā
(Aconitum heterophyllum Wall. ex. Royle) - Mustā (Cyperus rotundus L.) and Dāḍima
(Punica granatum L.) - Vṛkṣāmla (Garcinia indica Choisy.). It also emphasizes of the
literature on the trans-disciplinary research method which is used in this PhD thesis.
2.2 Methodology
Charaka Samhitā, Suśruta Samhitā, Aṣṭānga Sangraha and Aṣṭānga Hṛdaya - classical,
Ayurvedic encyclopedia of c. 15th Century BCE – 7th Century CE), Chikitsāgranthas
(Ayurvedic texts on pathophysiology and treatment written after 8th century CE ) and
Nighaṇṭus (lexicons of c. 10-16th century CE) were referred to review the concept of
APD in Ayurveda. Published Ayurvedic books, especially on Dravyaguṇa and Bhaiṣajya
Kalpanā, Ayurvedic Pharmacopoeia of India (API) and Formularies and articles in peer
reviewed journals on APD concept were also referred. The published books and literature
on the information about the habit, habitat, trade, phytochemistry and pharmacology of
the selected four plant species were obtained from the databases like PubMed and
SciFinder. The concepts of trans-disciplinary research were obtained from the published
literature in peer reviewed journals.
2.3 Relevance of APD concept
Contemporary herbal drug industry is facing problems of inadequate supply of crude
herbs for several reasons, prompting illegitimate or un-researched substitution and
adulteration. Meanwhile, over exploitation of threatened species to serve the demand
builds immense pressure on biological diversity (Ved and Goraya, 2008). Providing
Review of Literature
16
effective and safe substitution for unavailable drugs is the need of the day. Concept of
drug substitution is not new to Ayurveda and has been mentioned from Samhitā period
(1500 BCE) up to the Modern period (19th century CE). Several examples of unavailable
(AD) and substitutes (APD) have been mentioned in classical texts of Ayurveda (Misra,
2002; Mishra, 2007; Sastry, 2002). Unavailability of the original drug due to geographical
and/or seasonal variations would have led to substitution. Biodiversity and habitat loss
due to over-exploitation of some medicinal plant species and expanding human
population may have also pushed several species to near extinction and urged the need
for substitution. However, without valid reasoning, for the modern scientists not familiar
with Ayurveda as well as contemporary Ayurvedic practitioners, the substitution may
appear non-scientific, raising questions about the propriety of their use in treatment
(Nagarajan et al., 2015).
2.3.1 Need to select APDs
Bhaiṣajya Ratnāvalī gives an indication to go for APDs:
Kadāchit dravyamekam vā yoge yatra na labhyate | Tatguṇayuktam dravyam parivṛtena
grhyate || (Bhaiṣajya Ratnāvalī, Abhāva Prakaraṇa, 1)
Whenever a medicinal drug/ingredient in a formulation is not available, it is advised to
take another drug with similar guṇa (properties) (Mishra, 2007).
In addition to this, Bhāvaprakāśa says, ‘Anuktamapi yuktam yadyojayettadrasādivit’
(Bhāvaprakāśa, Miśrakaprakaraṇa, 166).
A material can be selected, even if it is not mentioned in a group of drugs indicated for
the treatment of a particular disease, provided, it has similar rasa etc. to that of the
drugs in the group. He has also mentioned the necessity of use of substitutes for the rare
drugs in Aṣṭavarga group (section 1.5.2) (Chunekar, 2004; Misra, 2002).
Review of Literature
17
2.3.2 APD concept in traditional knowledge
Charaka Samhitā theoretically approves the usage of APDs (Sastry, 1997a). Roots of
Eraṇḍa are indicated by Suśruta Samhitā and its commentator Dalhana instead Gokṣura
in the context of laghupanchamūla (Suśruta Samhitā, Sūtra Sthāna, 38/66) (Acharya,
1992). This has been supported by later written texts like Siddhasara Samhita (Ghildhiyal
et al., 2013). It was Bhāva Miśra, the medieval period Nighaṇtu writer, who stressed on
the need for APDs and suggested several APD herbs (Chunekar, 2004). Later, in the
modern era, Chikitsāgranthas like Bhaiṣajya Ratnāvalī (Mishra, 2007), Yogaratnākara
(Sastry, 2002), Chikitsāsāra Sangraha (Saxena, 2004) and Ayurveda Saukhyam (Dash,
1997) and regional language books like Vaidya Chintāmaṇi (Sarma, 1996) and
Swayamvaidya (Tiruka, 1991) mentioned APDs for several ADs. Apart from the codified
knowledge, living traditions also holds knowledge of APDs. Traditional practitioners found
to use APDs in several instances.
Kauṭilya in his Arthaśāstra documents that, substitution/adulteration of plant drugs
because of their high demand in trade (Krayavikraya) (Shamasastry, 2014). Substitution
of raw drugs is a common practice in Indian raw drug market. However the process of
substitute identification and reasons for using a particular substitute are not detailed in
the Ayurvedic texts (Nagarajan et al., 2015).
A list of fully referred AD-APD pairs in codified systems and living traditions and an
analysis of similarities and differences between the selected AD-APD pairs has been
provided in chapters 4 and 5.
Review of Literature
18
2.4 Research on the concept of APD
With rising concern for conservation of endangered medicinal species, serious attempts
are underway in different parts of the globe to find substitute herbs for endangered
ones. In India, AFI has approved some substitutes (AFI, 2000; AFI, 2003) (Section 2.4.1)
and Ayurvedic industry uses substitutes for several drugs, but the similarity in the
bioactivity of suggested substitute with the original drug has not been scientifically
established. The Ayurvedic concept of herbal drug substitution has not been explored by
scientists and by Ayurvedic scholars alike.
Some drug pairs (of unavailable and substitute) have been studied by scientists in stray
instances, but no effort has been made to understand the logic of substitution and to
bring it up to the level of formularies. A list of Ayurveda suggested APDs along with
preliminary yet systematic attempts to relate the APDs as in the case of Ativiṣā (A.
heterophyllum) and Mustā (C. rotundus) was the first report on APDs in contemporary
literature. It reports similarities not only at the level of Ayurvedic understanding, but also
in terms of phytochemical profiles and selected pharmacological actions
(Venkatasubramanian et al., 2010) of Ativiṣā and Mustā. Similar is the case with Vidārī
(Pueraria tuberosa) and Kṣīra Vidārī (Ipomoea mauritiana) (Venkatasubramanian et al.,
2009). Subsequently, some publications have discussed about this concept. A review by
Joshi and Patel (2012) mentions the possibility of adoption of APD concept in
contemporary situations. They have shown the relevance of substitution practices, like
the substitutes for Bṛhatī (Solanum indicum Linn.) which are not classically indicated
(Joshi and Patel, 2012). A review by Giri (2014) states the possible role of APD concept
in quality medicinal products and conservation of medicinal plants. They also urge the
need for re-validation of documented APDs in Ayurvedic literature and practiced by the
Ayurvedic Vaidyas (Giri, 2014).
Review of Literature
19
Substitution at the practice level, without a specified Ayurvedic logic was also scrutinized
for understanding the basis and validity of APD. Fruits of different species like Embelia
tsjeriam-cottam A.DC., Maesa indica (Roxb.) A.DC. and Myrsine africana L. sold in the
name of Viḍanga (Embelia ribes Burm. F.) showed similar bio-activity in terms of their
anthelmintic potential (Venkatasubramanian et al., 2013). However their chemical
profiles were not similar (Kuruvilla et al., 2010).
Some other candidates like Saraca asoca De wilde. are found to be substituted with
different species. Attempts have been made to relate the phytochemical and
chromatographic profiles of the original drug Saraca asoca with substitute drugs Saraca
declinata L. and Polyalthia longifolia Benth. Though some similarities between these
species have been observed, substantial pharmacological evidence has not been found to
consider them as substitutes (Khatoon et al., 2009).
Dāruharidrā (Berberis aristata DC.) is one of the species in high demand, but red listed
medicinal plants. Berberis asiatica Roxb., one of the substitutes for B. aristata indicated
by AFI has been proved to be legitimate, especially as an ingredient in the preparation of
hepatoprotective drugs (Andola and Purohit 2012). Systematic studies have been taken
up to study the Ayurvedic suggestion of Bṛhat Gokṣura (Pedalium murex L.) as a
substitute for Gokṣura (Tribulus terrestris L.), where the researchers observed
phytochemical and some pharmacological similarities between the pair (Renuka et al.
2012; Chandrika et al., 2012). The controversies regarding Aṣṭavarga group of herbs and
their substitution with other herbs have been studied by some of the experts in India
(Sharma and Balkrishan, 2008).
Substitution of medicinal plants is practised at international levels as well. Some attempts
were made to show the scientific relevance of such practices. Zschocke and Staden
Review of Literature
20
(2000) have reported the scarcity of Ocotea bullata (Burch.), an important medicinal
plant in South Africa. Their studies have shown that the abundantly available Cryptocarya
species could be its potential substitute in terms of cyclooxygenase-1 and -2 inhibition
activities (Zschocke and Staden, 2000). Root of Pelargonium sidoides, a plant in high
demand exported from Africa experienced a drastic drop in the population. A study
conducted by Lewu et al. (2006) has shown that the leaves of Pelargonium sidoides can
be used as substitute for its roots in the treatment of bacterial infections (Lewu et al.
2006).
2.4.1 Substitutes mentioned in Ayurvedic Formularies of India (AFI)
The Ayurvedic Formulary of India (AFI, Part 1 and 2) provides substitute species for
several plant drugs (Table 2.1) (AFI, 2000; AFI, 2003). Several substitutes in list have
been widely practiced in contemporary herbal drug market. Some of them have been
proved to be legitimate by scientific studies. E.g., Embelia robusta C.B.Clarke. (Syn. E.
tsjeriam-cottam (Roem. & Schult.) A. DC.) is a common substitute of Embelia ribes
Burm.f. and sold as Viḍanga. Venkatasubramanian and co workers (2013) proved the
comparable efficacy of substitute as an anthelmintic herbal medicine. They also have
examined the efficacy of two more market substitutes of E. ribes, namely Myrsine
africana L. (MA) and Maesa indica (Roxb.) DC. (Venkatasubramanian et al., 2013).
Some of the substitutes mentioned by AFI appear to be influenced by variations in
regional practices. E.g., Bergenia ligulata (Wall.) Engl. is used as Pāṣāṇabheda, to
manage urolithiasis. In South India, especially in the state of Kerala and surroundings
Aerva lanata Juss. is used for the same purpose (Sarin, 2008). AFI recognizes the former
plant as authentic species and the other as substitute for Pāṣāṇabheda (Anonymous,
2000; Anonymous, 2003).
Review of Literature
21
AFI has cited APDs mentioned in classical Ayurvedic texts only for rare Aṣṭavarga drugs
and not for any of the other ADs. E.g., For Medā (Polygonatum cirrhifolium Royle), it
suggests Asparagus racemosus Willd. as a substitute (Anonymous, 2000). A. racemosus
is Śatāvarī, an APD indicated by Bāvamiśra for both Medā and Mahāmedā (Chunekar,
2004). The other APDs given in the AFI are probably based on regional practice. The
methodology and supporting documents for recommending the APDs are also not
indicated in AFI.
Table 2.1: Substitutes mentioned in AFI, Parts 1 and 2
Sl.
No
Sanskrit name Authentic species Substitute/s (Anonymous,
2000; Anonymous, 2003)
1. Agnimantha Premna integrifolia Linn. Clerodendrum phlomidis Linn. f.,
Premna mucronata Roxb.
2. Amlavetasa Garcinia pedunculata
Roxb.
Rheum emodi Wall
3. Arka Calotropis procera (Ait)
R.Br
Calotropis gigantia (Linn.)
R.Br.ex Ait
4. Asphoṭa Vallaris heynei Spreng. Hemidesmus indicus R.Br.
5. Aśvakarṇa Dipterocarpus alatus
Roxb.
Terminalia tomentosa W.&A.
6. Ajamoda Apium graveolens (Linn.) Trachiospermum roxburghianum
(DC) Sprague
7. Bhārngī Clerodendrum serratum
(Linn) Moen.
Clerodendrum indicum (Linn)
Ktze.
8. Chaṇḍa
(Chorakabheda)
Angelica archangelica
Linn.
Angelica glauca Edgw.
9. Dāruharidrā Berberis aristata DC Berberis asiatica Roxb.ex.D.C/
Berberis lyceum Royle.
10. Dhānvayāsa Fagonia cretica Linn. Alhagi pseudalhagi (Bieb)Desv.
11. Dhattūra Datura metel Linn. Datura inoxia Mill.; Datura
stramonium Linn.
12. Dravantī Jatropha glandulifera
Roxb.
Croton tiglium Linn.
13. Dugdhikā Euphoria thymifolia Linn. Euphorbia prostrata W.Ait
14. Elāvāluka Prunus cerasus Linn. Prunus avium Linn.
15. Jīvaka Microstylis musifera
ridley.
Pueraria tuberosa D.C.
16. Kākolī Lilium polyphyllum D.Don Withania somnifera Dunal.
17. Ksīrakākolī Fritillaria roylei Hook. Withania somnifera Dunal.
18. Lāmajjaka Cymbopogon jwarancusa
Schult.
Vetiveria zizanioides (L) Nash
19. Madayantī Lawsonia inermis Linn. Jasminum sambac Ait.
Review of Literature
22
20. Mahāmedā Polygonatum cirrhifolium
Royle
Asparagus racemosus Willd.
21. Murā Selinium tenuifolium Wall. Nardostachys jatamansi D.C.
22. Mūrvā Marsdenia tenacissima
Weight and Arn.
Chonemorpha macrophylla
23. Mustā Cyperus rotundus Linn. Cyperus scariosus R.Br.; Cyperus
adundinaceum Baker
24. Nirviṣa Delphinium denudatum Kyllinga triceps roxb.
25. Pāṣāṇabheda Bergenia ligulata (Wall.)
Engl.
Aerva lanata Juss.
26. Priyangu Callicarpa macrophylla
Vahl.
Prunus mahaleb Linn.
27. Raktapunarnava Boerhavia diffusa Linn. Boerhavia repens Linn.;
Boerhavia rependa Willd.
28. Rāla/śāla Shorea robusta Gaertn. F. Vateria indica Linn.
29. Rāsnā Pluchea lanceolata
Oliver&Hiern.
Alpinia galangal Willd.
30. Reṇuka Vitex agnus-castus Linn. Vitex negundo Linn.
31. Rddhi Habenaria intermedia
D.Don
Dioscoria bulbifera Linn.
32. Rohiśa Cymbopogon martinii
(Roxb.)Wats.
Cymbopogon schoenanthus (L)
Sperng.
33. Rohitaka Tecomella undulata
(G.Don) Seem.
Aphanamixis polystachya (Wall)
Parker.
34. Somavallī Sarcostemma brevistigma
W.A.
Ephedra gerardiana Wall.
35. Spṛkka Anisomeles malabarica
(Linn.) R.Br.
Schizachyrium exile Stapf.;
Delphinium zalil Aitch&Hemsl.
36. Sṛuvavṛkṣa Flacourtia indica Merr. Gymnosporia spinosa (Forsk)
Fiori.
37. Svarṇakṣīrī Euphorbia thomsoniana
Bioss.
Argemone Mexicana Linn.
38. Tālīsa Abies webbiana Lindl. Abies pindrow Spach.; Taxus
baccata Linn.
39. Tuvaraka Hydnocarpus laurifolia
(Dennst.) Sleumer
Hydnocarpus kurzi (King) Wab.
40. Viḍanga Embelia ribes Burm.f. Embelia robusta C.B.Clarke.
41. Medā Polygonatum cirrhifolium
Royle
Asparagus racemosus Willd.
42. Vṛddhi Habenaria intermedia
D.Don.
Dioscoria bulbifera Linn.
Review of Literature
23
2.5 Literature review of ADs and APD’s shortlisted for scientific studies
Two sets of AD-APDs were analysed for the scientific validity of substitution. They are
Ativiṣā-Mustā and Dāḍima-Vṛkṣāmla. A brief review of published literature about these
species is given below.
Mustā has been suggested as the APD for Ativiṣā by Bhāvaprakāśa (Misra, 2002),
Yogaratnākara (Sastry, 2004) and Bhaiṣajya Ratnāvalī (Mishra, 2007). Vṛkṣāmla has been
advised as APD for Dāḍima by Bhaiṣajya Ratnāvalī (Mishra, 2007) and Chikitsāsāra
Sangraha (Saxena, 2004).
2.5.1 Ativiṣā
The Ayurvedic Formulary of India identifies Ativiṣā as Aconitum heterophyllum Wall. ex.
Royle (Ranunculaceae) (AFI, 2003).
2.5.1.1 Introduction to A. heterophyllum
More than 300 species are known in the Aconitum family (Been, 1992). A. napellus, A.
chasmanthum, A. ferox, A. palmatum and A. heterophyllum are commonly used
Aconitum species in Indian and Chinese medicine (Chopra and Chopra, 2006; Singhuber,
2009). A. heterophyllum is a perennial herb commonly found in the alpine and sub-alpine
regions above 3000 m. (Sarin, 2008; Nautiyal and Nautiyal, 2004). It has greenish-blue
coloured and helmet-shaped flowers (Fig. 2.1). The roots harvested from plants older
than 2 years are used for medicinal purposes. The tubers generally occur as a pair of
mother and daughter tubers (Fig. 6.1). In India, this species is naturally spread over
Jammu & Kashmir, Himachal Pradesh and in Uttarakhand (Srivastava et al., 2010).
Because of its endangered status, the export of plant portions and derivatives of A.
heterophyllum obtained from the wild is prohibited by the Director General of Foreign
Review of Literature
24
Trade (Zoo rules 1992). Cultivation of Ativiṣā has been attempted by both Government
and Non-government agencies in Uttarakhand as a resource augmentation effort
(Nautiyal and Nautiyal, 2004). The annual consumption of Ativiṣā in India is estimated to
be around 200-500 tonnes/year with the price varying from Rs. 2000-4000/kg (Ved and
Goraya, 2008).
Figure 2.1: Habit of A. hetrophyllum
Review of Literature
25
2.5.1.2 Phytochemistry of A. heterophyllum
Atisine is the main alkaloid in A. heterophyllum (Chatterjee and Prakash, 1994). It is non-
toxic and therefore, A. heterophyllum is a safer herb to use than other Aconitum species
(Sastry, 2005a). The process of shodhana (purification) is not mandatory for A.
heterophyllum.
Alkaloids: Alkaloids of A. heterophyllum were documented as early as the last decades
of the 19th Century (Jowett, 1896). Atisine was isolated and its molecular formula was
deduced by Broughton (Figure 2.2). Jowett and co-workers investigated the properties
and composition of atisine and its salts (Jowett, 1896). Alkaloids like hetisine,
heteratisine (Figure 2.2) and benzoylheteratisine were isolated by Jacobs and Craig
(1942). The chemical structures of hetisine, atisine and heteratisine were elucidated by
Pelletier and co-workers (Solo and Pelletier, 1962; Pelletier and Parthasarathy, 1965;
Aneja et al., 1973;). They have also isolated and elucidated the structures of diterpene
alkaloids: atidine, atisenol, F-dihydroatisine, hetidine and hetisone, isoatisine; lactone
alkaloids heterophyllisine, heterophylline and heterophyllidine; an entatisene diterpenoid
lactone, atisenol (Pelletier and Aneja, 1967; Pelletier et al., 1968; Pelletier and Ateya,
1982). Two aconitine-type norditerpenoid alkaloids, 6-dehydroacetylsepaconitine and 13-
hydroxylappaconitine were recently reported (Ahmad et al., 2008).
The aconitine content of A. heterophyllum was found to be 0.13 -0.75% (dry weight
basis), based on HPLC studies (Bahuguna et al., 2000; Pandey et al., 2008). Higher
quantities of atisine (0.35%) and aconitine (0.27%) (Figure 2.2) were reported in green
house grown A. hetrophyllum when compared to the naturally grown plants (0.19% and
0.16%, respectively) (Bahuguna et al., 2013). Another study reported 0.0014-0.0018%
aconitine from tubers of A. heterophyllum from the Kashmir valley (Jabeen et al., 2011).
Alkaloids are the main focus of study in A. heterophyllum and several pharmacological
actions of Ativiṣā have been attributed to them.
Review of Literature
26
Figure 2.2: Important phytoconstituents of A. heterophyllum
2.5.1.3 Pharmacology of A. heterophyllum
Members of Aconitum species (A. napellus, A. chasmanthum, A. ferox, A. palmatum and
A. heterophyllum) are used in Ayurveda and Chinese systems of medicine (Ukani et al.,
1996). The drug finds common use in the treatment of fevers, diarrhea, indigestion,
inflammation, helminthiasis, hyperlipidemia and as an anti-emetic in children (API,
2001a; Kirtikar and Basu, 1993a). Similar uses for A. heterophyllum are also found in
Unani and Siddha systems of medicines as well (Anonymous, 1993; Kirtikar and Basu,
1993a).
Antihyperlipidemic activity: The methanolic extract of tubers of Ativiṣa (A.
heterophyllum) decreased total cholesterol, LDL-c, triglycerides and apolipoprotein B in
blood serum diet induced obese rats. It decreased intestinal fat absorption also. Whereas
OCH3
OH
OCH3
OCH3
HO
NC2H5
OH
H3CO
O
C
O CH3
O
C
O
Aconitine (C34H47NO11)
CH2
N
CH3
H
H
OH
O
Iso-Atisine (C22H33NO2)
N
CH3
OCH3
O
O
OH
HO
Heteratisine (C22H33NO5)
CH3
CH2
O
O
OH
H
Atisenol (C20H28O3)
CH2
OH
H
N
CH3
H
H
O
Atisine (C22H33NO2)
Review of Literature
27
in rodents there was an increase in HDL-c and apolipoprotein A. Inhibition of
hydroxymethylglutarate- coenzyme A reductase (HMGR) and activation of Lecithin-
cholesterol acyltransferase (LCAT) was considerd to be reason for antilipidemic activities
(Subash and Augustine, 2012).
Anti-inflammatory and antipyretic activity: Ethanolic extracts of A. heterophyllum
showed anti-inflammatory activity in the cotton pellet induced granuloma test (Verma et
al., 2010). Antipyretic effects of its aqueous, chloroform and hexane extracts were seen
in rats with yeast induced pyrexia (Ikram et al., 1987).
Action on the nervous system: A. heterophyllum makes the sympathetic nervous
system more sensitive to physiological stimuli. Atisine has a hypotensive effect, but the
whole plant extract has hypertensive properties. Hypertension produced by high doses of
aqueous extract may be because of the excitement of the sympathetic nervous system
(Raymond-Hamet, 1938; Raymond-Hamet, 1954). Diterpenoid alkaloids heterophyllinines
A and B, were about 13 times more selective in inhibiting the enzyme
butyrylcholinesterase than acetylcholinesterase. These enzymes are involved in the
transmission of nerve impulses (Nisar et al., 2009).
Antibacterial activity: Aconitine type nor-diterpenoid alkaloids 6-
dehydroacetylsepaconitine and 13-hydroxylappaconitine, isolated from the tubers of A.
heterophyllum along with the known alkaloids lycoctonine, delphatine and lappaconitine,
displayed antibacterial activity against gram negative (diarrhea causing) bacteria
Escherichia coli, Shigella flexineri, Pseudomonas aeruginosa and Salmonella typhi
(Ahmad et al., 2008).
Review of Literature
28
Anthelminthic activity: Aqueous and alcoholic extracts of tubers of A. heterophyllum
had significant activity against Pheritema postuma (earthworm), compared to standard
piperazine citrate (Pattewar et al., 2012).
Immunomodulatory activity: The immunomodulatory activity of the ethanolic extract
of A. heterophyllum was exhibited in terms of delayed type hypersensitivity, humoral
responses to sheep red blood cells, skin allograft rejection and phagocytic activity of the
reticuloendothelial system in mice. It enhanced phagocytic function and inhibited the
humoral component of the immune system (Atal et al., 1986).
2.5.2 Mustā
Mustā has been recognized as Cyperus rotundus L. (Cyperaceae) by AFI (AFI, 2003).
2.5.2.1 Introduction to C. rotundus
C. rotundus, also known as purple nutsedge or nutgrass, is a common weed found all
over India in fields, agricultural land and moist waste land (Sarin, 2008). It is a tufted,
grass-like perennial plant, whose stem is three angled at the top with brown spikelets.
Inflorescences are small, consisting of tiny flowers with a red-brown husk (Fig. 2.3).
Rhizomes are 3-20mm in diameter, rust-coloured turning black (Fig. 6.2) with a
characteristic odour. The rhizomes from 2 year old plants are used for medicinal
purposes. Consumption of Mustā is estimated to be 2000-5000 tonnes per year with a
cost range of Rs.15-30/kg. (Ved and Goraya, 2008).
2.5.2.2 Phytochemistry of C. rotundus
Terpenoids are the major phytoconstituents in C. rotundus. Phenolics and flavonoids are
also present (Meena et al., 2010) and there is only one report on the occurrence of
alkaloids in C. rotundus (Jeong et al., 2000).
Review of Literature
29
Figure 2.3: A plant of C. rotundus
Terpenes: Cyperene, a sesquiterpene, cyperene, was isolated from the essential oils of
C. rotundus (Trivedi et al. 1964). A ketone, mustākone (Fig. 2.4), copadiene (a
conjugated diene), epoxyguaiene (an epoxide), rotundone and α-cyperone (Figure 2.4),
cyperolone (a hydroxy ketone) were found in C. rotundus (Kapadia et al., 1965). The
isolation and structure elucidation of rotundene and rotundenol (sesquiterpenoids) were
reported by Paknikar et al., 1977. Triterpenoid acid oleanolic acid and its glycoside was
isolated from the benzene extract of C. rotundus. (Singh and Singh 1980). The presence
of caryophyllene in C. rotundus was also reported (Dhillon et al., 1993). The chemical
constituents responsible the anti-malarial activity of C. rotundus were recognized as
Review of Literature
30
patchoulenone, caryophyllene alpha-oxide, 4, 7-dimethyl-1-tetralone and sesquiterpene
endoperoxide 10, 12-peroxycalamenene (Thebtaranonth et al., 1995).
Several sesquiterpenoids (Ohira et al., 1998), patchoulane type sesquiterpenes and
eudesmane types and nortriterpenoids were isolated from the rhizomes of C. rotundus
(Kim et al., 2012; Yang and Shi, 2012).
Glycosides: C. rotundus rhizomes were contained iridoid glycosides, rotundusides A and
B (Zhou and Zhang, 2013; Zhou et al., 2013). A Keto-alcohol, triterpenoid glycosides, 18-
epi-alpha-amyrin glucuronoside and oleanolic acid arabinoside were also reported (Alam
et al., 2012).
Tannins, flavanoids and coumarins were found to be present in all various extracts of C.
rotundus. The essential oil showed the presence of around 70 sesquiterpene
hydrocarbons along with oxygenated sesquiterpenes and a few monoterpene
hydrocarbons (Kilani et al., 2007). Norsesquiterpene norcyperone (Xu et al., 2008),
Epiguaidiol A and sugebiol, guaidiol, sugetriol triacetate, cyperenoic acid and
cyperotundone (Xu et al., 2009), sesquiterpenoids – rotundusolide A & B and
rotundusolide C were also reported (Yang and Shi, 2012).
Phenolics and flavonoids: The ethanolic extract of C. rotundus was reported contain
73.27± 4.26 g/100g of phenolic content (catechin equivalents) (Nagulendran, 2007).
Phenolics and flavonoids- quercetin, kaempferol, catechin and myrcetin (Samariya and
Sarin, 2013), luteolin, ginkgetin and isoginkgetin (Zhou and Fu, 2013) and phenolics
were also reported from C. rotundus (Zhou and Yin, 2012).
Alkaloids of C. rotundus: Jeong and co-workers (2000) reported 3 sesquiterpene
alkaloids from the rhizomes of C. rotundus, Rotundines A-C (Fig. 2.4) in small quantities
(0.7-1.1 ppm) (Jeong et al., 2000). Recently, a complex mixture of terpenoids and
alkaloids and condensed tannins in the rhizomes of C. rotundus, was observed during
histochemical studies on C. rotundus (Adams et al., 2013).
Review of Literature
31
Figure 2.4 Important Phytoconstituents of C. rotundus
Chemotypes of C. rotundus: Based on the composition of essential oils, 4 chemotypes
of C. rotundus have been reported. They are, H, M and O (found in Asia), K (common in
Hawaiian islands). Type O is most widely distributed. (Komai et al., 1991).
The composition of the essential oil of C. rotundus shows geographical variation. The
essential oils of C. rotundus from South India were found to have the dominance of α-
copaene (11.4%), valerenal (9.8%), caryophyllene oxide (9.7%), cyperene (8.4%),
nootkatone (Figure 2.4) (6.7%), and trans- pinocarveol (5.2%) (Jirovetz et al., 2004).
Whereas the samples from Dehradun showed 5-oxo-isolongifolene (16.27%), α-
gurjunene (10.22%), valerenyl acetate 8.88%) α-salinene (4.48%), valerenic acid
(3.67%) and γ-cadinene(3.4%) as the major components (Bisht et al., 2011).
N
X=
6
X
OHHX = , , epimeric at C-6, Rotundines B & C
O, Rotundine A
Alkaloids of Cyperus rotundus
O
Mustākone (C15H22O)
O
α-Cyperone (C15H22O)
Nootkatone (C15H22O)
Review of Literature
32
2.5.2.3 Pharmacology of C. rotundus
C. rotundus is used extensively in the management of fevers, diarrhoea, thirst,
inflammation, tastelessness, helminthiasis, indigestion and obesity in traditional Indian
medicine (Kirtikar and Basu, 1993b). Similar uses for C. rotundus are found in the Siddha
system as well (Anonymous, 1993).
Anti-obesity and anti-hyperlipidemic activity: In obese Zucker rats the hexane
extracts of C. rotundus rhizomes reduced weight gain by 10%, which was reasoned as
due to activation of the β3-AR (adrenoreceptor) (Lemaure et al., 2007). In another
study, the aqueous and alcoholic extracts lowered total cholesterol, triglyceride and low
density lipoprotein levels in serum in rats (Chandratre et al., 2011; Chandratre et al.,
2012).
Hypoglycemic activity: The hydro-alcoholic extract of C. rotundus rhizomes at
500mg/kg was as effective as metformin at 450mg/kg in reducing glucose levels in
alloxan induced hyperglycemic rats (Raut et al., 2006). It was proved to be capable of
inhibiting protein glycation, alpha-glucosidase and alpha-amylase (Ardestani and
Yazdanparast, 2007). A flavane, (2RS, 3SR)-3,4’,5,6,7,8-hexahydroxyflavane and the
stilbene dimers cassigerol E and scirpusins A and B were found to be responsible for this
activity (Thi et al., 2014).
Anti-diarrhoeal activity: The methanolic extract of C. rotundus had significant
antidiarrhoeal activity compared to loperamide (Uddin et al., 2006). The aqueous
decoction of C. rotundus rhizome showed significant inhibition of labile toxin and stable
toxin production of 2 groups of E. coli, EPEC (enteropathogenic) and ETEC
(enterotoxigenic). C. rotundus had limited antibacterial/anti-rotaviral activity. Mustā’s anti
diarrhoeal effect was attributed to action on some feature of bacterial virulence such as
Review of Literature
33
colonization, production of cholera toxin or labile toxin rather than killing the bacteria
(Birdi et al., 2011; Daswani et al., 2001).
Anti-inflammatory activity: C. rotundus essential oil was proved to have anti-
inflammatory, anti-arthritic, analgesic and anti-convulsant effect when studied using in
vitro and in vivo models (Biradar et al., 2010; Tsoyi et al., 2011, Kim et al., 2013, Jung et
al., 2013). The anti-inflammatory, analgesic and anti-genotoxic activity were attributed to
the flavonoids, tannins and polyphenols of C. rotundus (Soumaya et al., 2013)
Anti-microbial activity: Several reports state that C. rotundus has anti-microbial
activity. Its essential oil was active against gram positive micro-organisms (El-Gohary et
al., 2004). The hexane and water extracts were showed inhibition against B. pumilis (Sini
and Malathy, 2005). It suppressed Streptococcus mutans and the production of organic
acids by the same bacteria, thus proving it as an anticariogenic agent (Yu et al., 2007). It
has also showed various levels of antibacterial effect against Staphylococcus aureus,
Enterococcus faecalis, Escherichia coli, Salmonella enteritidis, and Salmonella
typhimurium, Bacillus subtilis, Enterococcus faecalis, Salmonella enteridis and Salmonella
typhimurium (Kilani et al., 2007; Bisht et al., 2011; Kilani-Jaziri et al., 2011). Significant
antifungal activity of C. rotundus compared to the standard drugs was observed against
C. parapsilosis and A. fumigates, F. oxysporum and A. flavus (Bisht et al., 2011), Candida
albicans and Aspergillus niger (Biradar et al., 2010).
Anthelmintic activity and Cytotoxic activity: Essential oil of C. rotundus has
showed anthelmintic activity against Pheretima postuma and Ascardia galli (Biradar et al.,
2010). The essential oil of C. rotundus rhizomes showed positive result against Ehrlich
ascites carcinoma cells with 100% inhibition, but not against human tumor cell lines (El-
Gohary et al., 2004).
Review of Literature
34
CNS activity: Ethanolic extract of C. rotundus rhizome showed CNS depressant activity..
It enhanced sleeping time, had analgesic and anticonvulsant activities and reduced
different behavioral reflexes (Pal et al., 2009). The total oligomeric flavanoids (TOFs)
obtained from rhizomes of C. rotundus had neuroprotective effects. It helped to relieve
oxidative stress and improved neurological behavioral alterations in rats subjected to
middle cerebral artery occlusion and reperfusion (Sunil et al., 2009). Neuroprotective
function of Mustā was also proved by in vitro studies also (Kandikattu et al., 2013;
Kumar and Khanum, 2013).
Antioxidant activity: Studies proved that, C. rotundus is a potent antioxidant herbal
drug. Its hydro-alcoholic, ethyl acetate extracts exhibited free radical scavenging,
reducing power, antimutagenic, radical scavenging and antigenotoxic and metal chelating
activities (Kilani et al., 2007; Nagulendran et al., 2007). It was also proved to have anti-
cataract activity (Seema et al., 2007). Extracts of Mustā inhibited xanthine oxidase,
superoxide anion and protected against hydrogen peroxide/UV induced DNA damage.
The extract exerted antiproliferative effect towards K 562 erythroleukemia cells (Kilani-
Jaziri et al., 2009). The rhizomes had anti-oxidant activity in DPPH assay and inhibition of
linoleic acid lipid peroxidation (Pal and Dutta, 2006; Bashir et al., 2012). A significant
decrease in mucosal damage was reported on administration of C. rotundus, suggesting
its free radical scavenging activity (Guldur et al., 2010). Extracts of the aerial parts of C.
rotundus also reduced genotoxicity induced by nifuroxazide and aflatoxin B1 (Kilani-Jaziri
et al., 2011).
Anti-allergic activity: The anti allergic activity of C. rotundus was proved by both in
vitro and in vivo studies. Its sesquiterpenes inhibited release of histamines and 5– LOX
Review of Literature
35
(lipoxygenase) enzyme. The ethanol extracts and isolated sesquiterpenes, monoterpenes
& 4-cymene were found to be effective. (Jin et al., 2011).
Antiplatelet activity: The ethanolic extract of C. rotundus and nootkatone were
capable of inhibiting platelet aggregation, which was confirmed by in vivo studies in rats,
prolonging the bleeding time. (Seo et al 2011).
Insecticidal and plasmodicidal activity: C. rotundus was active against “Asian tiger
mosquito” (Kempraj and Bhat, 2008) and three other mosquito species, which shows its
role as insecticidal agent (Singh et al., 2009). C. rotundus hexane extract was active
against Plasmodium falciparum (Thebtaranonth et al., 1995) as well as German
cockroach (Blatella germanica L.) (Chnag et al., 2012).
Review of Literature
36
2.5.3 Dadima
Dāḍima has been recognized as Punica granatum L. (Punicaceae) (AFI, 2003).
2.5.3.1 Introduction to P. granatum
Dāḍima (P. granatum) is a glabrous small tree, growing up to a height of 3 m. It is native
to Iran and extensively cultivated in China, Northern India, California, and Mediterranean
region (Rahimi et al., 2012). Leaves are opposite or sub-opposite; obovate or oblong.
Flowers are terminal or axillary, scarlet or orange-red coloured. Fruits are either red or
pale greenish depending up on the variety. They are globose and crowned with the limb
of calyx (API, 1999) (Figure 2.5). Edible part is the seeds/arils, which are angular and
coriaceous (Figure 5.8). Fruit rinds are also used in management of indigestion related
diseases (Sharma, 2006b).
Figure 2.5 Fruits of P. granatum
Review of Literature
37
2.5.3.2 Phytochemistry of P. granatum
Tannins: P. granatum has hydrolysable tannins like ellagitanins and gallotanins as major
components. They are found in different parts of the plant. Though several tannins are
reported from different parts of P. granatum tree, gallic acid and ellagic acid (Figure 2.6)
are the major tannins isolated from the juice (Wang et al., 2010).
Leaves contain tannins like brevifolin, brevifolin carboxylic acid, ethyl
brevifolincarboxylate, corilagin, ellagic acid, gallic acid (figure 2.6), β-D-glucose,
punicafolin, strictinin, tercatain, 5-O-galloyl-punicacortein D. The peel contains 2,3-(S)-
HHDP-D-glucose, granatin B. Bark is rich in castalagin, casuariin, casuarinin,
punicacortein A and B, punicacortein C, punicacortein D, punicalin and punicalagin
(Rahimi et al., 2012)
Flavonoids: Flavones, flavanols, anthocyanidins and flavan-3-ols are the common
flavonoids of P. granatum. Major flavonoids present in the juice are catechin, catechol,
cyanidin-3-glucoside, cyanidin-3,5-diglucoside, cyanidin-3-rutinoside, delphinidin-3-
glucoside, delphinidin 3, 5-diglucoside, pelargonidin 3-glucoside, pelargonidin 3,5-
diglucoside, epicatechin, epigallocatechin-o-gallate, flavan-3-ol, quercitin and epiquercitin
(Rahimi et al., 2012). The brilliant red colour of pericarp and juice is attributed to
anthocyanidins and flavan-3-ols, which greatly vary during the stages of maturity of the
fruits. Anthocyanidins of pomegranate are in the form of glycosides with the aglycons of
delphinidin, cyaniding and pelargonidin. (Wang et al., 2010).
Alkaloids: Though the juice contains some alkaloids, they are mainly found in the stem
and root. They are of two types, piperidines and pyrrolidines (Wang et al., 2010).
Tryptamine, serotonin and melatonin are mainly found in the juice. Peelletierine, N-
methylpelletierine, pesudopelletierine are commonly found in bark and roots (Neuhofer
Review of Literature
38
et al., 1993). Roots and rinds of pomegranate tree have up to 3% and 0.6% of alkaloids
respectively (Mohammad and Kashani, 2012).
Organic acids: Pomegranate juice mainly contains organic acids like citric acid and
malic acid, tartaric acid and oxalic acid (Rahimi et al., 2012).
Terpenes: Triterpenes like ursolic acid, oleolinic acid, punicanolic acid and steroids like
stigmasterol, camesterol and beta- sitosterol are present in pomegranate fruit juice and
rind (Wang et al., 2010).
Ellagic Acid Derivatives: Pomegranate fruit, pericarp and bark contain ellagic acid.
Seeds are rich in 3,3′-di-O-methyl ellagic acid and 3,3′, 4′-tri-O-methyl ellagic acid. The
trees heartwood contains ellagic acid and diellagic acid rhamnosyl(1-4) glucoside (Rahimi
et al., 2011).
Figure 2.6: Important Phytoconstituents of P. grantum
Ellagic acid (C14H6O8)
Gallic acid (C7H6O5)
Brevifolin (C10H12O4)
Corilagin (C27H22O18)
Review of Literature
39
2.5.3.3 Nutritional value of pomegranate
Pomegranate is a highly acclaimed fruit having good nutritional value. Table 2.2 provides
the nutritive value of pomegranate.
Table 2.2: Nutritional value of pomegranate fruit (per 100 g of edible pulp) (Adapted
from Garach et al., 2012)
Composition Quantity
Water 80-82 g
Energy 63-68 Kcal
Carbohydrates 16.4 g
Protein 0.5-0.9 g
Fat 0.3-0.9 g
Ash 0.5 g
Phosphorous 8 mg
Iron 0.3 mg
Potassium 259 mg
Calcium 3 mg
Sodium 3 mg
Manganese 3 mg
Zinc 0.12 mg
Magnesium 015 mg
Copper 0.07 mg
Selenium 0.6 mg
Panthothenic acid 0.59 mg
Vitamin B1 0.03 mg
Vitamin B2 0.03 mg
Vitamin B3 0.03 mg
Vitamin C 4-6 mg
2.5.3.4 Pharmacology of P. granatum
In traditional medicine, pomegranate is widely used in the management of heart
diseases, indigestion problems, stomach disorders and anemia. Its rind is used in the
management of dental diseases, diarrhoea and skin diseases (Bhowmik et al., 2013).
Antioxidant activity: The polyphenols and flavonoids in the juice were considered to
control oxidative stress which in turn causes lipid peroxidation in arterial macrophages
and in lipoproteins (Noda et al., 2002). Pomegranate displayed hydroxyl radical and
superoxide anion scavenging activity, which was related to the presence of
anthocyanidins (Guo et al., 2007; Seeram et al., 2006).
Review of Literature
40
Anti-inflammatory activity: Pomegranate inhibited cyclooxygenase (COX) and
lipooxygenase (LOX) (Schubert et al., 1999; Rahimi et al., 2011). It was showed to have
ability to manage osteoarthritis by reducing inflammation, as well as by preventing
collagen degeneration (Ahmed et al., 2005). It also controled colitis in rats (Larrosa et
al., 2010).
Anti-cancer activity: Several in vitro and in vivo studies indicate the therapeutic
potential of pomegranate in prostate cancer. Gallic acid and its polyphenols were found
to be responsible for its therapeutic role in cancer (Khodzhaeva et al., 1985; Lansky et al.
2007). In vitro and animal studies by Sturgeon and Ronnenberg (2010) showed that
pomegranate has the capacity to prevent breast cancer. They have explained the
possible mechanisms involved in this action (Sturgeon and Ronnenberg, 2010). One of
the constituents of pomegranate, punicic acid, was capable of inhibiting the proliferation
breast of cancer cell line MDA-MB-231. During the study, apoptosis of cells was also
observed, which was explained to be due to lipid peroxidation of cells and activation of
protein kinase C (PKC) (Grossmann et al., 2010).
Hypertension: Through a clinical trial pomegranate was proved as an antihypertensive
drug along with its ability to inhibit serum angiotensin converting enzyme (ACE). In
patients administered with pomegranate juice, there was about a 5% reduction in
systolic blood pressure (Yurdasheva et al., 1978).
Neuroprotection: Pomegranate juice, especially the polyphenols are known to have a
role in neuroproction. There was a decrease in accumulation of soluble amyloid-beta in
transgenic mice (with Alzheimer’s like pathology) treated with pomegranate juice. Their
memory and learning capacity also improved (Zelepukha et al., 1975).
Review of Literature
41
Antimicrobial activity: The methanolic extract of pomegranate peel was an inhibitor of
several microbes including Listeria monocytogenes, Staphylococcus aureus, Escherichia
coli and Yersinia enterocolitica (Julie et al., 2008). It suppressed the growth of
pathogenic clostridia and Staphylococcus aureus (Bialonska et al., 2009). It was also
active against norovirus infections (Su et al., 2010) and influenza virus (Haidari et al.,
2009). The peel extract, especially punicalgin, was active against fungal species
Paracoccidioides brasiliensis, Candida albicans and Candida parapsilosis (Endo et al.,
2010). Sun-dried rind of the immature fruit of P. granatum is used as malaria
prophylaxis. Methanolic extracts of pomegranate inhibited Plasmodium falciparum and
Plasmodium vivax (Dell’Agli et al. 2009)
Glucose and lipid metabolism: Pomegranate flower extract was orally fed to
streptozotocin-induced diabetic rats and potent anti-hyperlipidemic and hypoglycemic
activity was observed (Bagri et al., 2009). It was also seen that pomegranate leaf tannins
modulate the lipid metabolism and act on liver cells (Lan et al. 2009).
Cardiovascular health: Pomegranate is considered to be a cardio protective food. P.
granatum juice and its polyphenol rich extracts had activity against platelet aggregation.
Polyphenol rich extracts showed action against platelet activation (Mattiello et al., 2009).
The rats fed with pomegranate juice were shown to have better cardiac health in terms
of plasma marker enzymes, lipid peroxidation, Ca2+ ATPase, endogenous enzymatic and
non-enzymatic antioxidants compared to the controls (Jadeja et al., 2010).
Skin protection: Pomegrante juice and derived products were effective in preventing
the damage caused by ultra violet rays in human reconstituted skin (EpiDermTM FT-200)
(Afaq et al., 2009)
Review of Literature
42
Hepatoprotection: A beverage produced from pomegranate flowers was proved to be
effective to prevent liver damage induced by trichloroacetic acid. In rats treated with
pomegranate juice, lower levels of alanine aminotransferase (ALT), aspartate
aminotransferase (AST), creatine kinase (CK), malonaldehyde contents in liver, brain,
kidney and hearth tissues were seen compared to the controls (Celik et al. 2009)
2.5.4 Vṛkṣāmla
Vṛkṣāmla is Garcinia indica Choisy. (Clusiaceae) (AFI, 2003).
2.5.4.1 Introduction to G. indica
Vṛkṣāmla (G. indica), a member of Mangosteen family is indigenous plant of India. Genus
garcinia has more than 200 species, of which most of them are endemic to South-East
Asia. G. indica is naturally grown and often cultivated in small scale in the humid regions
of Western Ghats in India (Figure 2.7) (Ramachandran, 2014).
Figure 2.7: Habit of G. indica
Review of Literature
43
It is a medium sized, evergreen glabrous tree growing up to a height of 20 m. Fruiting
season is April-May. The useful part is its dark red coloured fruit (Figure 2.7) containing
3-4 large seeds, embedded in whitish, sweet-sour pulp and connected to the rind (Pasha
and Ramachandran, 2014).
Fruit rinds (fresh/dried) (Fig. 6.9) are used both in medicinal and culinary preparations. It
is added to curries to give sour taste and red colour. Generally, the fresh fruits are cut
into halves, the pulp and seeds are separated from the rind and the rinds are sun dried
for a week. This primary process gives a longer shelf life to the rinds. Syrup prepared
from the rinds of G. indica is often sweetened, diluted with water used as refreshing cold
drink in summer (Kureel et al., 2009). Seeds yield around 25% fat, known as Kokum
butter, which is used as a topical application in burns and skin diseases, apart from
culinary preparations (Ramachandran, 2014). India produces more than 10,000 metric
tons of Kokum every year (Kureel et al., 2009).
2.5.4.2 Nutritional value of Vṛkṣāmla
G. indica is an acidic fruit, rich in organic acids. Table 2.3 gives the proximate
composition of fresh fruits of Vṛkṣāmla.
Review of Literature
44
Table 2.3: Nutritional value of G. indica (per 100 g of fruit) (Kureel et al., 2009;
Parthsarathy and Nandakishore, 2014; Pasha and Ramachandran, 2014)
Composition Quantity
(In fresh fruit rinds)
Water 80 g
Sugars 4.1 g
Protein 1-1.92 g
Fat 1.4 g
Tannins 1.7-2.6 g
Pectin 1-5.7 g
Organic acid 5.9 g
Anthocyanins 2.4 g
Crude fiber 14.28 g
Ash 2.6 g
(In dry rinds)
Iron 12.06mg
Potassium 44.5 mg
Calcium 13.21 mg
Sodium 1.55 mg
Phosporous 0.45 mg
Magnesium 33.45 mg
Vitamin B1 (Thiamin) 52 µg
Vitamin B2 (Riboflavin) 275 µg
Vitamin B3 (Niacin) 45 µg
Vitamin C (Ascorbic acid) 14.35 mg
Vitamin B12 8.75 µg
Total vitamins 14.75 mg
Total acidity 14.11 %
HCA 7.43%
Malic acid 2.67%
Oxalic acid 0.63%
Citric acid 0.79%
Tartaric acid 0.51%
Acetic acid 0.31%
Total phenols 5.01 g
2.5.4.3 Phytochemistry of G. indica
Vṛkṣāmla or Kokum is popular for its organic acids that give characteristic acidic taste
and water soluble anthocyanins that give attractive pink-red colour to the fruits. It also
has garcinol, a polyisoprenylated benzophenone derivative, known for many of the
nutraceutical actions of G. indica. Kokum is valued as it is a rich source of hydroxycitric
acid (HCA), a proven anti lipidemic molecule (Jayaprakasha and Sakariah, 2002). Its
phytochemical analysis showed the presence of terpeniods, alkaloids, saponins,
Review of Literature
45
flavanoids, glycosides & carbohydrates, phenolic, tannins and phytosterols (Pasha and
Ramachandran, 2010).
Organic acids: Hydroxycitric acid (1,2 dihydroxypropane-1,2,3-tricarboxylic acid) is the
main organic acid in the rinds of many Garcinia species, and in G. indica as well. This
citric acid derivative is also called as garcinia acid. Rinds usually contain about 7-20 % of
(-)-HCA on dry basis (Fig. 2.8). Low amounts of HCA and HCA-lactone were detected in
Kokum leaves also (Jayaprakasha and Sakariah, 2002). Citric, malic and ascorbic acid are
also present in the rinds. (Pasha and Ramachandran, 2014).
Flavonoids: G. indica has anthocyanin glycosides, polyphenols- a proauthocyanidin and
a biflavanoid. Its anthocyanins give the characteristic red colour to the fruit. It has red
pigments up to 3 %. The pigments are cyanidin-3-glucoside and cyanidin-3-
sambubioside, with sugar association of glucose and xylose, respectively. Red coloured
Garcinia anthocyanins are water soluble. Xanthones, benzophenones, lactones and
phenolic acids are also reported from G. indica (Nayak and Rastogi, 2010).
Figure 2.8: Important Phytoconstituents of G. indica
(-)-Hydroxycitric acid (C6H8O8)
General structure of Anthocyanidins
Garcinol (C38H50O6)
Review of Literature
46
Garcinol: G. indica has a yellow pigment called garcinol or camboginol (C38H50O6) up
to 3%. It is basically a polyisoprenylated benzophenone derivative with multiple phenolic
hydroxyl groups (Fig. 2.8) and shows potent antioxidant activity. (Nayak and Rastogi,
2010; Pasha and Ramachandran, 2014).
2.5.4.4 Pharmacology of G. indica
Vṛkṣāmla is a home remedy to treat several digestion problems like diarrhea and
dysentry, flatulence, allergies, burns, scalds, wounds. It is also a popular appetizer as
well as liver and cardio-tonic (Elumalai and Eswaraiah, 2011). However, it is most
popular as a obesity controlling herbal drug (Parthsarathy and Nandakishore, 2014)
Antioxidant activity: The water and alcoholic extracts of G. indica rinds (500mg/kg)
showed significant (P<0.01) antioxidant activity when studied using rodent models with
measure of sulphoxide dismutase (SOD), glutathione (GSH), lipid peroxidation (LPO) and
catalase (CAT). The activity was comparable to the standard drug silymarin (70 mg/Kg)
(Deore et al., 2011). Several preparations like Kokum syrup have antioxidant potential
due to the presence of garcinol and anthocyanins (Mishra et al., 2006). Yamaguchi et al.,
(2000) was also reported the free radical scavenging activity of garcinol against 2,2-
diphenyl-1-picrylhydrazyl (DPPH) radicals (Yamaguchi et al., 2000).
Anticancer activity: Garcinol has been studied for its anti cancer activity using several
models. Studies by Sang and co workers reported it to have better anti-tumor activity
when compared to curcumin. Garcinol induced apoptosis in human leukemia HL-60 Cells.
It was observed to have potent anti oxidant activity and inhibited Nitrous Oxide radical
generation and LPS-induced iNOS gene expression (Sang et al., 2002).
Review of Literature
47
Hepatoprotective activity: G. indica aqueous and ethanolic extracts showed potent
hepato protection against carbon tetrachloride induced hepato-toxicity in Wistar albino
rats. There was a significant reduction in biochemical parameters i.e., aspartate
transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (ALKP) and serum
bilirubin (SBRN) (Deore et al., 2011).
Anti obesity activity: Several studies report the anti-lipidemic and anti obesity actions
of hydroxycitric acid (HCA). This compound was also reported to reduce blood sugar by
enhancing cellular consumption of glucose (Sullivan and Triscari, 1977). It inhibited
lipogenesis and increased activity of carnitine palmitoyl transferase (CPT 1), which is a
rate limiting factor in fat burning and thus helps in weight loss (Sullivan and Triscari,
1977). HCA was also observed to inhibit ATP:citrate lyase, an enzyme having an
influential role in fatty acid synthesis from carbohydrates. It catalyzes cleavage of citrate
to acetyl-CoA and oxaloactate (a molecule essential for the formation of fats from
carbohydrates) and regulates fatty acid synthesis. (Jena et al., 2002).
Antimicrobial and cytotoxic activity: Water extract of G. indica was active against
bacterial species Escherichia coli, Bacillus subtilis, Enterobacter aerogenes and
Staphylococcus aureus and fungi- Candida albicans and Penicillium. Its fruit rind extract
inhibited cultures of 3T3 mouse fibroblasts (Varalakshmi et al., 2010).
Anti ulcer activity: The aqueous and ethanol extract of Kokum showed protection
against gastric mucosal damage under experimental conditions. It was active in
preventing damage caused by multiple ulcer-inducers, viz., indomethacin, HCl and
ethanol. Oral administration of 500 mg/kg of Kokum extract were showed significant anti
ulcer activity in rat models (Deore et al., 2011).
Review of Literature
48
2.6 Trans-disciplinary research (TDR) Methods
Several research problems, especially those originating from societal practices requires a
different approach than usual focused science research to solve them. They require a
trans-disciplinary research (TDR) model, which gives equal scope for ‘societal knowledge’
and ‘scientific knowledge’ (Lang et al., 2012) (Figure 2.9). TDR is the scientific inquiry
that cuts “across disciplines, integrates and synthesizes content, theory and methodology
from any discipline area and improves the quality, acceptance and sustainability of the
knowledge originating from research (Gray, 2008).
The research approaches to establish the legitimacy of different species used as Viḍanga
(Venkatasubramanian et al., 2013) and the studies performed to unravel the
bioequivalence of Ativiṣā and Mustā (Venkatasubramanian et al., 2010) are some of the
TDR approaches towards the concept of APD.
Figure 2.9: A simplified TDR model (Adapted from Lang et al., 2012)
SOCIETAL
PRACTICE
SCIENTIFIC
PRACTICE
Review of Literature
49
2.7 Conclusion
The review of literature on APDs was undertaken to understand the contemporary
knowledge about the subject. Herbal medicine sector and Ayurveda practice is facing the
problems of unavailability of raw drugs, along with adulteration and unauthentic
substitution. In spite of stringent restrictions introduced by the Government, several
medicinal plant species are exploited.
In this scenario, the Ayurvedic concept of APD may be useful, but it is not properly
utilized. There is lack of clarity about the logic of selection of APDs in Ayurveda. There is
also noticeable dearth of systematic studies either from Ayurvedic and scientific
perspectives. Probably, all these factors inhibit the Ayurvedic drug sector to use and
regulatory authorities to permit the practice APDs.
The need for a systematic documentation of APDs both from Ayurvedic literature and
practices is observed from the literature survey. Further, the documented APDs have to
be analysed to understand the logic behind suggesting specific substitutes and the
worthiness of such APDs compared to the ADs. It requires a systematic, trans-disciplinary
research (TDR) approach to find the answers to several questions about APDs including
the logic, and to reach back to the stake holders.